KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Nektar Therapeutics (NKTR) over the last 13 years, with Q2 2025 value amounting to $552307.0.

  • Nektar Therapeutics' Treasury Shares changed 0.0% to $552307.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $552307.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $552307.0 for FY2024, which is N/A changed from last year.
  • Nektar Therapeutics' Treasury Shares amounted to $3.0 million in Q2 2025, which was down 0.0% from $3.0 million recorded in Q1 2025.
  • Nektar Therapeutics' Treasury Shares' 5-year high stood at $9.9 million during Q4 2021, with a 5-year trough of -$552307.0 in Q1 2024.
  • In the last 4 years, Nektar Therapeutics' Treasury Shares had a median value of $552307.0 in 2024 and averaged $2.7 million.
  • Over the last 5 years, Nektar Therapeutics' Treasury Shares had its largest YoY gain of 0.0% in 2025, and its largest YoY loss of 0.0% in 2025.
  • Quarter analysis of 2 years shows Nektar Therapeutics' Treasury Shares stood at $3.0 million in 2024, then changed by 0.0% to $3.0 million in 2025.
  • Its last three reported values are $552307.0 in Q2 2025, $552307.0 for Q1 2025, and $552307.0 during Q4 2024.